Evalion is building the AI-native platform for clinical trials. Every drug that reaches patients passes through a process that's barely changed in fifty years — manual coordination, years of delay, billions in cost, and lives lost along the way. We're replacing that machinery with AI agents that source patients, run pre-screening, and monitor compliance in real time, all inside an audit architecture regulators trust.

Founded by Marcelo (serial entrepreneur — his last company scaled from zero to $1B+ revenue), Miguel (ex-Google engineering leader, pioneer of conversational AI agents in healthcare), and Mo (physician with two decades as a healthcare investor and policy advisor). Product and engineering are based in Barcelona; commercial in Boston/NYC. Backed by Javier Olivan (COO, Meta), Fidji Simo (CEO Applications, OpenAI), Guillermo Rauch (CEO, Vercel), and top institutional AI investors. We're assembling a small, elite team with global ambition.

Jo...